Detail of the clinical trial
Title of the trial | A phase II/III randomized, open-label study to compare the efficacy and safety of intravenous volasertib in combination with subcutaneous cytarabine versus investigator´s choice of anti-leukemic treamtent in adult patients with relapsed or refractory acute myeloid leukemia with no established treatment options (POLO-AML 1) |
---|---|
EudraCT number | 2010-023499-25 |
Protocol number | 1230.25 |
Sponsor | Boehringer Ingelheim RCV GmbH & Co. KG, Rakousko |
Indications | Hemato-oncology |
Diagnosis | leukemia |
Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
Year of receiving the request to Institute (SÚKL) | 2011 |
Date of approval by Institute (SÚKL) | 26.7.2011 |
Date of approval by EC | 27.6.2011 |
Date of initiation CT in ČR | |
Date of ending CT in ČR | |
Notice | |
Sites |
FN Hradec Králové, 2. interní klinika - odd. klnické hematologie Ústav hematologie a krevní transfuze, Praha 2 1. LF UK a VFN, I. interní klinika, Praha FNKV, Odd. klinické hematologie, Praha 10 |